Pharmacotherapy of Psychotic Disorders in Türkiye: Insights From a National Prescription Database
ABSTRACT Objective Psychotic disorders, affecting 3–7 per 1000 individuals, significantly impair mental functioning. Although antipsychotic medications represent the mainstay of treatment, prescribing practices can vary based on patient characteristics and across different countries. Currently, nati...
Saved in:
| Main Authors: | Sena Türkeş, Aybeniz Civan Kahve, Taner Çin, Esra Şafak Yılmaz, Hakkı Gürsöz, Süreyya Barun |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-07-01
|
| Series: | Brain and Behavior |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/brb3.70712 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacogenetics biomarkers of antipsychotics’ safety in adolescents with acute psychotic episode
by: D. V. Ivashchenko, et al.
Published: (2019-12-01) -
Short and long-term effects of cognitive behavioral therapy on sleep problems and psychotic symptoms in patients with psychotic disorders: a meta-analysis
by: Mustafa Ugurlu, et al.
Published: (2025-03-01) -
Comparative Efficacy of Lorazepam and Risperidone in Hospitalized Cannabis-induced Psychotic Disorder
by: Arshdeep Jhalli, et al.
Published: (2024-02-01) -
Acute Schizophrenia-like Psychotic Disorder Against the Background of COVID-19
by: Lidia Bravve, et al.
Published: (2025-02-01) -
Analyser l’activité de médecins hospitaliers pour concevoir la formation : le cas de la prescription de neuroleptiques
by: Aurélie Grass, et al.
Published: (2007-04-01)